Key result
Adolescent blood cancer survivors exhibited significantly lower resilience compared to adolescents with congenital heart disease (mean score 121.83 vs 129.27, p=0.03), though quality of life did not differ.
Why the study?
The study was conducted to compare resilience and quality of life between adolescent blood cancer survivors and adolescents with congenital heart disease to identify patterns and influencing factors.
Does resilience and quality of life differ between adolescent blood cancer survivors and adolescents with congenital heart disease?
Cross-Sectional (n=175)
Yes
Does resilience and quality of life differ between adolescent blood cancer survivors and adolescents with congenital heart disease?
Absolute Event Rate: 121.83% vs 129.27%
p-value: p=0.03
Adolescent blood cancer survivors exhibit significantly lower resilience compared to adolescents with congenital heart disease, highlighting the need for disease-specific psychosocial support programs.
May warrant resilience screening in blood cancer survivors; hypothesis-generating and requires longitudinal validation before guiding care.
BACKGROUND: The resilience and Quality of Life (QOL) of adolescent cancer survivors was compared with those of children with other diseases to identify the patterns and factors that affect resilience and QOL The purpose of the present study was to compare the resilience and QOL between adolescent blood cancer survivors and adolescents with Congenital Heart Disease (CHD). METHODS: A cross-sectional study was conducted in two hospitals. Ninety-four adolescent blood cancer survivors and 81 adolescents with CHD completed a self-reported questionnaire regarding resilience, QOL, and general characteristics. Independent t-test and ANCOVA were used to compare the resilience and QOL between adolescent blood cancer survivors and adolescents with CHD. RESULTS: The resilience of adolescent blood cancer survivors was significantly lower than that of adolescents with CHD, and the QOL of adolescent blood cancer survivors was not different from that of adolescents with CHD. CONCLUSIONS: The experiences of adolescent blood cancer survivors were different from those of adolescents with CHD even though they are of the same ages. Adolescents with chronic disease have a different level of illness controllability and self-regulation according to their disease and situation. Therefore, health-providers need to develop the specific programs for improving resilience and QOL of adolescents with chronic illness with focusing their characteristics and situations.
No takes yet. Share an insight, caveat, or question.
Lee et al. (2020) conducted a cross-sectional in Adolescent blood cancer and Congenital Heart Disease (n=175). Blood cancer survivorship vs. Congenital heart disease was evaluated on Resilience score (p=0.03). Adolescent blood cancer survivors exhibited significantly lower resilience compared to adolescents with congenital heart disease (mean score 121.83 vs 129.27, p=0.03), though quality of life did not differ.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: